Drug data last refreshed 8h ago · AI intelligence enriched 6d ago
Chorionic gonadotropin (hCG) is a naturally occurring hormone produced during pregnancy, approved as an injectable biologic for fertility treatment. It is used to trigger final oocyte maturation and ovulation in assisted reproductive technology (ART) cycles and to support luteal phase progesterone production. The drug mimics the endogenous LH surge required for reproductive function.
As a 50-year-old product approaching loss of exclusivity, the brand team is likely focused on lifecycle management and niche positioning rather than expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Comparative Bioavailability Study of Human Chorionic Gonadotropin (hCG)-IBSA Versus a Marketed hCG Formulation
A Randomised Trial Using Highly Purified Human Chorionic Gonadotropin (HP-hCG) and Recombinant Human Chorionic Gonadotropin (rhCG) in Women Undergoing Controlled Ovarian Stimulation
Administration of Follicle-stimulating Hormone (FSH) and Low Dose Human Chorionic Gonadotropin (hCG) for Oocyte Maturity While Decreasing hCG Exposure in In Vitro Fertilization (IVF) Cycles
HCG (Human Chorionic Gonadotropin) Priming for Thin Endometrium in IVF (in Vitro Fertilization)
Worked on CHORIONIC GONADOTROPIN at Ferring Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Working on chorionic gonadotropin offers exposure to specialty fertility marketing and regulatory stewardship in a niche, relationship-driven market. Careers here prioritize customer retention and compliance rather than launch innovation, making it suitable for professionals seeking stable, focused roles in women's health.